184 related articles for article (PubMed ID: 35043284)
1. The role of folate receptor-positive circulating tumor cell analysis in the diagnosis of colorectal cancer: a retrospective cohort study.
Yan S; Guo W; Liu Y; Li K; Wang W
Int J Clin Oncol; 2022 Mar; 27(3):538-544. PubMed ID: 35043284
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of colorectal cancer based on folate receptor-positive circulating tumor cell analysis: a retrospective cohort study.
Wei ZJ; Zhou BC; Wang GX; Han WX; Li YX; Xu AM
Int J Clin Oncol; 2024 Feb; 29(2):149-158. PubMed ID: 38112831
[TBL] [Abstract][Full Text] [Related]
3. The value of folate receptor-positive circulating tumor cells in the diagnosis of lung cancer and its correlation with clinical characteristics.
Xu Y; Li Q; Lin Z; Lin Y
Clin Respir J; 2023 May; 17(5):374-383. PubMed ID: 36977421
[TBL] [Abstract][Full Text] [Related]
4. Folate-receptor-positive circulating tumor cells as an efficacious biomarker for the diagnosis of small pulmonary nodules.
Xue Y; Cong W; Xie S; Shu J; Feng G; Gao H
J Cancer Res Ther; 2018; 14(7):1620-1626. PubMed ID: 30589049
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of colorectal cancer liver metastases based on liquid biopsy combined with folate receptor- Positive circulating tumor cells and HSP90.
Huang M; Cheng L; Mo S; Ru H; Mo X; Yan L
Front Oncol; 2022; 12():912016. PubMed ID: 36203415
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of folate receptor-positive circulating tumor cells in patients with esophageal squamous cell carcinomas: a retrospective study.
Zhou Q; He Q; He W; Wang C; Liu G; Wang K; Li H; Li J; Xiao W; Fang Q; Peng L; Han Y; Wang D; Leng X
BMC Cancer; 2023 Nov; 23(1):1171. PubMed ID: 38037003
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of cell surface vimentin positive circulating tumor cells as a prognostic biomarker for stage III/IV colorectal cancer.
Yu J; Yang M; Peng T; Liu Y; Cao Y
Sci Rep; 2023 Nov; 13(1):18791. PubMed ID: 37914786
[TBL] [Abstract][Full Text] [Related]
8. Six-gene Assay as a new biomarker in the blood of patients with colorectal cancer: establishment and clinical validation.
Shou X; Li Y; Hu W; Ye T; Wang G; Xu F; Sui M; Xu Y
Mol Oncol; 2019 Apr; 13(4):781-791. PubMed ID: 30556647
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor cells as an independent prognostic factor in advanced colorectal cancer: a retrospective study in 121 patients.
Wang L; Zhou S; Zhang W; Wang J; Wang M; Hu X; Liu F; Zhang Y; Jiang B; Yuan H
Int J Colorectal Dis; 2019 Apr; 34(4):589-597. PubMed ID: 30627849
[TBL] [Abstract][Full Text] [Related]
10. Clinical Potential of Circulating Tumor Cells in Colorectal Cancer: A Prospective Study.
Baek DH; Kim GH; Song GA; Han IS; Park EY; Kim HS; Jo HJ; Ko SH; Park DY; Cho YK
Clin Transl Gastroenterol; 2019 Jul; 10(7):e00055. PubMed ID: 31246593
[TBL] [Abstract][Full Text] [Related]
11. Sensitivity and specificity of folate receptor α-positive circulating tumour cells in gastric cancer.
Cao B; Liu L; Zhang R; Dong H; Shen J
Postgrad Med J; 2024 Jan; 100(1180):112-119. PubMed ID: 37973392
[TBL] [Abstract][Full Text] [Related]
12. Novel Circulating Tumor Cell Assay for Detection of Colorectal Adenomas and Cancer.
Tsai WS; You JF; Hung HY; Hsieh PS; Hsieh B; Lenz HJ; Idos G; Friedland S; Yi-Jiun Pan J; Shao HJ; Wu JC; Lai JM; Chang SE; Mei R; Watson D; Javey M; Nimgaonkar A
Clin Transl Gastroenterol; 2019 Oct; 10(10):e00088. PubMed ID: 31663904
[TBL] [Abstract][Full Text] [Related]
13. CD133+CD54+CD44+ circulating tumor cells as a biomarker of treatment selection and liver metastasis in patients with colorectal cancer.
Fang C; Fan C; Wang C; Huang Q; Meng W; Yu Y; Yang L; Peng Z; Hu J; Li Y; Mo X; Zhou Z
Oncotarget; 2016 Nov; 7(47):77389-77403. PubMed ID: 27764803
[TBL] [Abstract][Full Text] [Related]
14. Folate receptor-positive circulating tumor cells in the preoperative diagnosis of indeterminate pulmonary nodules.
Li Z; Cai J; Zhao Y; Cai J; Zhao X
J Clin Lab Anal; 2022 Oct; 36(10):e24654. PubMed ID: 36217263
[TBL] [Abstract][Full Text] [Related]
15. Folate receptor-positive circulating tumor cells predict survival and recurrence patterns in patients undergoing resection for pancreatic cancer.
Cheng H; Yang J; Fu X; Mao L; Chu X; Lu C; Li G; Qiu Y; He W
Front Oncol; 2022; 12():1012609. PubMed ID: 36313690
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of a novel one-stop ISET device to capture CTCs and its clinical application.
Chen F; Wang S; Fang Y; Zheng L; Zhi X; Cheng B; Chen Y; Zhang C; Shi D; Song H; Cai C; Zhou P; Xiong B
Oncotarget; 2017 Jan; 8(2):3029-3041. PubMed ID: 27935872
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Circulating Tumor Cells in Colorectal Cancer as an Adjunctive Non-invasive Diagnostic Method.
Nursyirwan SA; Abdullah M; Sulaiman AS; Rinaldi I; Makmun D; Simadibrata M; Noor DR; Wiraatmadja A; Jeo WS; Rahadiani N; Handjari DR; Shatri H
Acta Med Indones; 2023 Oct; 55(4):385-395. PubMed ID: 38213054
[TBL] [Abstract][Full Text] [Related]
18. Detection of folate receptor-positive circulating tumor cells as a biomarker for diagnosis, prognostication, and therapeutic monitoring in breast cancer.
Wu Q; Zheng H; Gu J; Cheng Y; Qiao B; Wang J; Xiong L; Sun S; Wu Z; Bao A; Tong Y
J Clin Lab Anal; 2022 Jan; 36(1):e24180. PubMed ID: 34919735
[TBL] [Abstract][Full Text] [Related]
19. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
[TBL] [Abstract][Full Text] [Related]
20. The value of folate receptor-positive circulating tumour cells as a diagnostic biomarker for lung cancer: a systematic review and meta-analysis.
Chen F; Ni Y; Zhang J; Hao Y; Tian Z; Qiang G
J Int Med Res; 2023 Sep; 51(9):3000605231199763. PubMed ID: 37751487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
